Daiichi and Merck's I-Dxd lung cancer study faces partial hold due to deaths
Daiichi and Merck's I-Dxd lung cancer study faces partial hold due to deaths
Contenido no disponible. Consulta la fuente original.
Daiichi and Merck's I-Dxd lung cancer study faces partial hold due to deaths
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.